Release date: 2008-12-03 Medical Hospital Bed,Patient Bed,Electric Hospital Bed,Adjustable Hospital Bed Hebei Dingli Medical Equipment Co., Ltd. , https://www.dinglimed.com
Recently, a breakthrough in diabetes diagnosis has been made by researchers at Zhongnan Hospital of Wuhan University. They have successfully developed a gene diagnostic tool that can identify mitochondrial diabetes within just one day. This achievement marks the hospital as the first in China to introduce a DNA diagnostic chip for diabetes screening.
The research was led by Professor Zhou Xin, who has spent four years developing this advanced technology. The gene chip is expected to go into mass production next year. By using high-quality chips, doctors can screen individuals with diabetes, those at high risk, and even healthy people, helping in accurate diagnosis and classification. If a person is found to carry a mutated gene, they can take preventive measures such as increasing physical activity and maintaining a balanced diet. These steps can help reduce or delay the onset of the disease and prevent serious long-term complications.
Mitochondrial diabetes mellitus (MIDD) has emerged as a significant advancement in molecular genetics research in recent years. It is an inherited condition that typically begins before the age of 45, though cases have been reported as early as 11 years old and as late as 81. One of the unique features of MIDD is its association with mild to moderate neurological hearing loss. However, the development of deafness and diabetes may not occur simultaneously, sometimes being separated by up to 20 years.
This innovative approach represents a major step forward in personalized medicine and could greatly improve early detection and treatment strategies for patients at risk. The work by Zhongnan Hospital of Wuhan University is setting a new standard in diabetes care and genetic research.
——Shanghai Medical Device Industry Association